Predicting the Risk of Weight Loss After Esophageal Cancer Surgery
- PMID: 31004297
- PMCID: PMC6611892
- DOI: 10.1245/s10434-019-07352-5
Predicting the Risk of Weight Loss After Esophageal Cancer Surgery
Abstract
Background: Malnutrition after esophageal cancer surgery is associated with reduced health-related qualify of life. Therefore, a prediction model identifying patients at risk for severe weight loss after surgery was developed.
Methods: Data from a Swedish population-based cohort study, including 616 patients undergoing esophageal cancer surgery in 2001-2005, was used. Candidate predictors included risk factors available before and immediately after surgery. Severe weight loss was defined as ≥ 15% loss of body weight between the time of surgery and 6 months postoperatively. The prediction model was developed using multivariable models. The accuracy of the model was measured by the area under the receiver operating characteristics curve (AUC) with bootstrap validation. The model was externally validated in a hospital-based cohort of 91 surgically treated esophageal cancer patients in the United Kingdom in 2011-2016. Each predictor in the final model was assigned a corresponding risk score. The sum of risk scores was equivalent to an estimated probability for severe weight loss.
Results: Among the 351 patients with 6 months follow-up data, 125 (36%) suffered from severe postoperative weight loss. The final prediction model included body mass index at diagnosis, preoperative weight loss, and neoadjuvant therapy. The AUC for the model was 0.78 (95% CI 0.74-0.83). In the validation cohort, the AUC was 0.76. A clinical risk assessment guide was derived from the prediction model.
Conclusions: This prediction model can preoperatively identify individuals with high risk of severe weight loss after esophageal cancer surgery. Intensive nutritional interventions for these patients are recommended.
Figures
Similar articles
-
Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer.Dis Esophagus. 2012 Aug;25(6):527-34. doi: 10.1111/j.1442-2050.2011.01282.x. Epub 2011 Nov 28. Dis Esophagus. 2012. PMID: 22121887
-
Body mass index kinetics and risk factors of malnutrition one year after radical oesophagectomy for cancer.Eur J Cardiothorac Surg. 2012 May;41(5):1088-93. doi: 10.1093/ejcts/ezr182. Epub 2012 Feb 13. Eur J Cardiothorac Surg. 2012. PMID: 22334635
-
Prediction Model of Long-term Survival After Esophageal Cancer Surgery.Ann Surg. 2021 May 1;273(5):933-939. doi: 10.1097/SLA.0000000000003431. Ann Surg. 2021. PMID: 33824250
-
Application of four nutritional risk indexes in perioperative management for esophageal cancer patients.J Cancer Res Clin Oncol. 2021 Oct;147(10):3099-3111. doi: 10.1007/s00432-021-03585-8. Epub 2021 Mar 9. J Cancer Res Clin Oncol. 2021. PMID: 33687565 Free PMC article.
-
Prospective Study of Malabsorption and Malnutrition After Esophageal and Gastric Cancer Surgery.Ann Surg. 2015 Nov;262(5):803-7; discussion 807-8. doi: 10.1097/SLA.0000000000001445. Ann Surg. 2015. PMID: 26583669
Cited by
-
Association of Malnutrition, as Defined by the PG-SGA, ESPEN 2015, and GLIM Criteria, With Complications in Esophageal Cancer Patients After Esophagectomy.Front Nutr. 2021 Apr 26;8:632546. doi: 10.3389/fnut.2021.632546. eCollection 2021. Front Nutr. 2021. PMID: 33981719 Free PMC article.
-
Postoperative Complications of Free Flap Reconstruction in Moderate-Advanced Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study Based on Real-World Data.Front Oncol. 2022 Jun 24;12:792462. doi: 10.3389/fonc.2022.792462. eCollection 2022. Front Oncol. 2022. PMID: 35814388 Free PMC article.
-
Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II study.Chin J Cancer Res. 2024 Jun 30;36(3):270-281. doi: 10.21147/j.issn.1000-9604.2024.03.04. Chin J Cancer Res. 2024. PMID: 38988486 Free PMC article.
-
Long-term changes in bone mineral density in postoperative patients with esophageal cancer.Ann Gastroenterol Surg. 2022 Nov 29;7(3):419-429. doi: 10.1002/ags3.12640. eCollection 2023 May. Ann Gastroenterol Surg. 2022. PMID: 37152773 Free PMC article.
-
Weight loss, glycolipid profile changes in type 2 diabetes patients after esophagectomy: a propensity score matching analysis.Surg Endosc. 2024 Jun;38(6):3405-3415. doi: 10.1007/s00464-024-10852-5. Epub 2024 May 9. Surg Endosc. 2024. PMID: 38724646 Free PMC article.